RUDNICK SETH

Track

Insider profile

RUDNICK SETH's trades of G1 Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
414.62
Quantity 82,649 -33.3%
Value US$3,426,735
Transaction date
Planned sale
Price
423.26
Quantity 22,958 +38.1%
Value US$3,633,286
Transaction date
Planned sale
Price
330.50
Quantity 73,374 +28.4%
Value US$1,413,506
Transaction date
Planned sale
Price
20.00
Quantity 546 -1.4%
Value US$10,921
Transaction date
Planned sale
Price
20.32
Quantity 5,773 -12.9%
Value US$117,284
Transaction date
Planned sale
Price
20.19
Quantity 13,161 -22.8%
Value US$265,694
Transaction date
Planned sale
Price
20.09
Quantity 520 -0.9%
Value US$10,449
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-12-29 2020-12-24
PlS Planned sale
82,649 -33.3%
414.62
US$3,426,735 		82,649 -33.3% 414.62 US$3,426,735
2020-12-23 2020-12-23
PlS Planned sale
22,958 +38.1%
423.26
US$3,633,286 		22,958 +38.1% 423.26 US$3,633,286
2020-12-23 2020-12-22
PlS Planned sale
73,374 +28.4%
330.50
US$1,413,506 		73,374 +28.4% 330.50 US$1,413,506
2020-12-10 2020-12-10
PlS Planned sale
546 -1.4%
20.00
US$10,921 		546 -1.4% 20.00 US$10,921
2020-12-10 2020-12-09
PlS Planned sale
5,773 -12.9%
20.32
US$117,284 		5,773 -12.9% 20.32 US$117,284
2020-12-10 2020-12-08
PlS Planned sale
13,161 -22.8%
20.19
US$265,694 		13,161 -22.8% 20.19 US$265,694
2020-12-03 2020-12-01
PlS Planned sale
520 -0.9%
20.09
US$10,449 		520 -0.9% 20.09 US$10,449